ENVIFAR: The Visiting Child and His Family in ICU

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Unknown status
CT.gov ID
NCT03954522
Collaborator
(none)
240
1
20.1

Study Details

Study Description

Brief Summary

According to literature, it's difficult to evaluate the impact of the visit of the child in ICU. Currently, no recommendations are available regarding welcome and accompany children who visit their relative hospitalized in ICU. Collaboration between humanities and medical sciences brings to this question a complementary look. Majority of studies investigated the question of the impact of young child ICU visit in a unidirectional linear causality scheme visit = psychopathological impact. The visit of the child in ICU should not be considered as an isolated event whose objective characteristics would be alone vectors of trauma. Contrary, the child visit must be apprehended in relation to the quality of the supports on which the child can count. The investigators hypothesize that children can overcome the visit of a kin hospitalized in ICU if accompanying people can support the child and contain, before and after the visit, the emotions of the child.

Condition or Disease Intervention/Treatment Phase
  • Other: interview
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluation in Children of the Psychological Impact of the Visit of a Hospitalized Relative in ICU
Anticipated Study Start Date :
Jun 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Feb 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Expérimental

psychologist interview and psychometrics scales

Other: interview
Child = A clinical interview (recorded, duration approximately 30 min) and a scale of acute stress (IES child) will be performed at 2 times (during the 7 days following the first visit of hospitalized kin and 1 month after the kin was discharged from ICU) Accompanying parent/kin = Semi-directive interviews (recorded - duration approximately 30 min) will be performed at the same time as those of the child and will be recorded. The parent/kin will also complete a socio-demographic questionnaire of the family group and a depression anxiety scale (HADS) Nursing staff = A semi-directive interview (recorded - duration approximately 30 min) will be performed only once (during the 7 days following the first visit to the hospitalized kin). The caregiver will also complete a socio-demographic questionnaire and a Moral Distress Scale (MDS-R) Hospitalized parent = One month after ICU discharge, a depression anxiety scale (HADS) and an acute stress scale (IES) will be performed

Outcome Measures

Primary Outcome Measures

  1. Acute psychotraumatic impact of the visit on the child [7 days]

    Scale of stress (Child IES-R : Impact of Event Scale- Revised) : score calculated on 40 points. A score of 17 or greater is considered as clinically relevant

  2. Chronic psychotraumatic impact of the visit on the child [1 month]

    Scale of stress (Child IES-R : Impact of Event Scale- Revised) : score calculated on 40 points. A score of 17 or greater is considered as clinically relevant

  3. Psychological experience of the visit for the child [7 days]

    semi directive interview

  4. Parental, family and caregiver support provided to the child during and following the visit [1 month]

    semi directive interviews of caregiver/family

  5. Psychological experience of the visit according the child age [1 month]

    semi directive interview analysed in subgroup: comparison between child aged from 6 to 10 years old versus 11 to 14 years old

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • family groups in which at least one child aged 6 to 14 years having expressed the wish to visit his/her hospitalized relative

  • family groups in which the non-hospitalized parent has expressed the wish to accompany his/her child during the visit

  • parent hospitalized in ICU is at least 18 years old

  • informed consent of children, non-hospitalized and/or hospitalized relatives

  • informed consent of the accompanying caregiver

Exclusion Criteria:
  • moribund patient

  • child unaccompanied by his/her parent/relative during the visit

  • non-hospitalized non-French-speaking parent/relative (need to be able to answer the questionnaires)

  • child benefiting from a psychological follow-up prior to the hospitalization of his/her parent

  • non French-speaking child

  • child under 6 years old or older than 14

  • hospitalized relative who died before the proposed interview with the child (particular attention will be carry out to the interview conditions. The loss of the hospitalized parent will not allow for an interview on the experience of the visit).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT03954522
Other Study ID Numbers:
  • P/2018/354
First Posted:
May 17, 2019
Last Update Posted:
May 17, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Besancon
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2019